Inicio › Enfermedad de obstrucción pulmonar crónica › Luisiana
Ensayos clínicos de Enfermedad de obstrucción pulmonar crónica en Luisiana
9 estudios sobre Enfermedad de obstrucción pulmonar crónica buscan participantes en Luisiana.
Ciudades en Luisiana
Texto oficial del estudio (inglés)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Southern Clinical Research - Zachary- Site Number : 8400113, Zachary
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07190209Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Care Access - Shreveport - Youree Drive- Site Number : 8400007, Shreveport
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 15 sept 2026 · NCT07190222A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
- GSK Investigational Site, Lake Charles
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 9 sept 2026 · NCT07780669A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Zachary
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT07082738A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Southern Clinical Research, LLC, Zachary
ReclutandoFase 2/3
Edades de 35 a 80 · Todos los sexos · Actualizado el 31 ago 2026 · NCT07363694A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Lafayette
- Research Site, Monroe
- Research Site, Zachary
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 26 ago 2026 · NCT06283966STRIVE Post-Market Registry Study
- LSU Health Shreveport, Shreveport
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 ago 2026 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Lake Charles
- GSK Investigational Site, Shreveport
ReclutandoFase 3
Edades de 40 a 75 · Todos los sexos · Actualizado el 28 jul 2026 · NCT07177339Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Baton Rouge
- GSK Investigational Site, Lafayette
- GSK Investigational Site, Shreveport
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 9 abr 2026 · NCT06961214De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.